Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

February 27, 2020

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.